A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker

[1]  R. Whittaker,et al.  Mobile phone text messaging and app-based interventions for smoking cessation. , 2019, The Cochrane database of systematic reviews.

[2]  A. Kiyosue,et al.  Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial , 2019, Journal of medical Internet research.

[3]  T. Betsuyaku,et al.  Impact of a Novel Smartphone App (CureApp Smoking Cessation) on Nicotine Dependence: Prospective Single-Arm Interventional Pilot Study , 2018, JMIR mHealth and uHealth.

[4]  K. Fukunaga,et al.  A Novel Smoking Cessation Smartphone App Integrated With a Mobile Carbon Monoxide Checker for Smoking Cessation Treatment: Protocol for a Randomized Controlled Trial , 2018, JMIR research protocols.

[5]  R. West,et al.  Smokers’ Views on Personal Carbon Monoxide Monitors, Associated Apps, and Their Use: An Interview and Think-Aloud Study , 2018, International journal of environmental research and public health.

[6]  K. McGeechan,et al.  Smartphone Smoking Cessation Application (SSC App) trial: a multicountry double-blind automated randomised controlled trial of a smoking cessation decision-aid ‘app’ , 2018, BMJ Open.

[7]  Edwin D Boudreaux,et al.  A systematic review of smartphone applications for smoking cessation , 2017, Translational behavioral medicine.

[8]  Nicholas J Schork,et al.  Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation , 2017, JMIR mHealth and uHealth.

[9]  K. Perkins,et al.  Validating Use of Internet-Submitted Carbon Monoxide Values by Video to Determine Quit Status , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[10]  J. Beckham,et al.  Abstinence Reinforcement Therapy (ART) for rural veterans: Methodology for an mHealth smoking cessation intervention. , 2016, Contemporary clinical trials.

[11]  L. Beebe,et al.  Assessment of the Tobacco Dependence Screener Among Smokeless Tobacco Users. , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[12]  Ashutosh Kumar Singh,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[13]  Dan J Stein,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, BDJ.

[14]  Robert West,et al.  A Mobile App to Aid Smoking Cessation: Preliminary Evaluation of SmokeFree28 , 2015, Journal of medical Internet research.

[15]  Julie A Kientz,et al.  Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy. , 2014, Drug and alcohol dependence.

[16]  S. Akter,et al.  mHealth for Smoking Cessation Programs: A Systematic Review , 2014, Journal of personalized medicine.

[17]  Jesse Dallery,et al.  A mobile-phone-based breath carbon monoxide meter to detect cigarette smoking. , 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[18]  D. Schroeder,et al.  Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. , 2014, JAMA.

[19]  M. Naghavi,et al.  Adult Mortality Attributable to Preventable Risk Factors for Non-Communicable Diseases and Injuries in Japan: A Comparative Risk Assessment , 2012, PLoS medicine.

[20]  M. Naghavi,et al.  What has made the population of Japan healthy? , 2011, The Lancet.

[21]  S. Heishman,et al.  Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatment-seeking smokers. , 2010, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[22]  M. Hara,et al.  Validity and reliability of Kano Test for Social Nicotine Dependence. , 2009, Annals of epidemiology.

[23]  T. Ishibashi,et al.  Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. , 2007, Clinical therapeutics.

[24]  David Gonzales,et al.  Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial , 2006 .

[25]  S. Tonstad,et al.  Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. , 2006, JAMA.

[26]  Robert West,et al.  Outcome criteria in smoking cessation trials: proposal for a common standard. , 2005, Addiction.

[27]  R. West,et al.  Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal , 2004, Psychopharmacology.

[28]  H. Shimizu,et al.  Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. , 1999, Addictive behaviors.

[29]  Sheila M. Alessi,et al.  Treatment Satisfaction in a Randomized Clinical Trial of mHealth Smoking Abstinence Reinforcement. , 2017, Journal of substance abuse treatment.